China Pharma Holdings, Inc.
CPHI· NYSE
Filed May 14, 2012 · 10-Q · 44 days after period end · 0001010549-12-000533
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $16.09M | $18.12M |
| Net Income | $2.81M | $5.10M |
| EPS Diluted | $0.06 | $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 14, 2012 · 44 d after period end